Palliser's Smith On Activist Investing in Japan
Palliser Capital Founder & CIO James Smith discusses the prospects of activist investing in Japan. He speaks with Annabelle Droulers from the sidelines of 'Sohn Hong Kong Investment Leaders Conference'. (Source: Bloomberg)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
Tech leader unveils groundbreaking laptop concept that runs on sunlight and folds flat like a book: 'Worth keeping an eye on'
Lenovo has been known to push the boundaries of laptop design, and its latest concept devices continue to deliver fresh innovations that include solar power. At Mobile World Congress 2025, the laptop maker revealed both the Lenovo ThinkBook Flip AI PC and Yoga Solar PC concepts, which could inform the next generation of consumer laptops. CNBC said that given the company's track record of bringing these innovative designs to market, "it's worth keeping an eye on what the Chinese technology giant is up to." The ThinkBook "codename Flip" AI PC, as the company called it, showed off an outward folding OLED display that can provide 18 inches of visual workspace or be folded over for a tablet-style interface. Workflows powered by artificial intelligence, split-screen multitasking, and smart workspace adaptation are being tested in this unique design. Sustainable power is also on the mind of Lenovo engineers, who worked up the Yoga Solar PC proof of concept to help capture the power of the sun to extend the device's runtime. This model includes a photovoltaic cell with 24% energy conversion efficiency, which is one of the best ratings available on the market, the company said. It's achieved through its Back Contact Cell technology, which places brackets and gridlines behind the solar cell for maximum absorption. Its Dynamic Solar Tracking system monitors the panel's current and voltage, working alongside the Solar-First Energy system for prioritizing the sun's rays for energy savings and stability. It can even generate power in low-light conditions while the PC is idle. The Yoga Solar PC can convert enough direct sunlight in 20 minutes to power up to one hour of video playback, according to the company. Measuring just 15 millimeters thin and weighing approximately 2.7 pounds, it's being called the world's first ultra-slim solar-powered PC. This improves upon Samsung's NC215S, which was reportedly the first laptop to include an integrated solar panel in 2011 and needed two hours of sunlight to run for one hour. Engineers and designers are realizing the potential of harnessing the sun's rays to power devices big and small across a variety of applications. What kind of solar tech would you be the most willing to use? Rooftop panels Community solar A portable solar generator None of the above Click your choice to see results and speak your mind. By leveraging renewable energy sources at every opportunity, we can more rapidly eliminate the use of dirty fuels and promote a cleaner, safer environment. Aptera's battery-powered electric vehicle includes solar panels on much of its exterior that help extend its runtime, while other companies have designed portable solar cells to help charge electric vehicles while parked. Lenovo has a track record of sustainable endeavors, championing repairs when possible to reduce waste, and offering cash for trade-ins so they can handle old devices more responsibly. Mary Jacques, Lenovo's executive director of Global ESG and Regulatory Compliance, told The Cool Down last year: "Our customers are really hungry for more and more information about not just the products that they're buying, but the impact that we can have on their sustainability journey." Join our free newsletter for weekly updates on the latest innovations improving our lives and shaping our future, and don't miss this cool list of easy ways to help yourself while helping the planet.
Yahoo
29 minutes ago
- Yahoo
Is West Pharmaceutical Services, Inc. (NYSE:WST) Potentially Undervalued?
West Pharmaceutical Services, Inc. (NYSE:WST) saw a decent share price growth of 11% on the NYSE over the last few months. The recent rally in share prices has nudged the company in the right direction, though it still falls short of its yearly peak. As a large-cap stock with high coverage by analysts, you could assume any recent changes in the company's outlook is already priced into the stock. However, could the stock still be trading at a relatively cheap price? Today we will analyse the most recent data on West Pharmaceutical Services's outlook and valuation to see if the opportunity still exists. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. The stock seems fairly valued at the moment according to our valuation model. It's trading around 11% below our intrinsic value, which means if you buy West Pharmaceutical Services today, you'd be paying a fair price for it. And if you believe the company's true value is $236.69, then there's not much of an upside to gain from mispricing. Is there another opportunity to buy low in the future? Since West Pharmaceutical Services's share price is quite volatile, we could potentially see it sink lower (or rise higher) in the future, giving us another chance to buy. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market. See our latest analysis for West Pharmaceutical Services Future outlook is an important aspect when you're looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. West Pharmaceutical Services' earnings over the next few years are expected to increase by 32%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value. Are you a shareholder? WST's optimistic future growth appears to have been factored into the current share price, with shares trading around its fair value. However, there are also other important factors which we haven't considered today, such as the financial strength of the company. Have these factors changed since the last time you looked at the stock? Will you have enough confidence to invest in the company should the price drop below its fair value? Are you a potential investor? If you've been keeping an eye on WST, now may not be the most optimal time to buy, given it is trading around its fair value. However, the positive outlook is encouraging for the company, which means it's worth diving deeper into other factors such as the strength of its balance sheet, in order to take advantage of the next price drop. It can be quite valuable to consider what analysts expect for West Pharmaceutical Services from their most recent forecasts. At Simply Wall St, we have the analysts estimates which you can view by clicking here. If you are no longer interested in West Pharmaceutical Services, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
32 minutes ago
- Yahoo
Is It Too Late To Consider Buying W.W. Grainger, Inc. (NYSE:GWW)?
Today we're going to take a look at the well-established W.W. Grainger, Inc. (NYSE:GWW). The company's stock saw a double-digit share price rise of over 10% in the past couple of months on the NYSE. Shareholders may appreciate the recent price jump, but the company still has a way to go before reaching its yearly highs again. As a large-cap stock with high coverage by analysts, you could assume any recent changes in the company's outlook is already priced into the stock. However, could the stock still be trading at a relatively cheap price? Today we will analyse the most recent data on W.W. Grainger's outlook and valuation to see if the opportunity still exists. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. W.W. Grainger appears to be overvalued by 22% at the moment, based on our discounted cash flow valuation. The stock is currently priced at US$1,088 on the market compared to our intrinsic value of $892.94. This means that the opportunity to buy W.W. Grainger at a good price has disappeared! But, is there another opportunity to buy low in the future? Since W.W. Grainger's share price is quite volatile, this could mean it can sink lower (or rise even further) in the future, giving us another chance to invest. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market. See our latest analysis for W.W. Grainger Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. With profit expected to grow by a double-digit 13% over the next couple of years, the outlook is positive for W.W. Grainger. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation. Are you a shareholder? It seems like the market has well and truly priced in GWW's positive outlook, with shares trading above its fair value. At this current price, shareholders may be asking a different question – should I sell? If you believe GWW should trade below its current price, selling high and buying it back up again when its price falls towards its real value can be profitable. But before you make this decision, take a look at whether its fundamentals have changed. Are you a potential investor? If you've been keeping an eye on GWW for a while, now may not be the best time to enter into the stock. The price has surpassed its true value, which means there's no upside from mispricing. However, the positive outlook is encouraging for GWW, which means it's worth diving deeper into other factors in order to take advantage of the next price drop. In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. Case in point: We've spotted 2 warning signs for W.W. Grainger you should be aware of. If you are no longer interested in W.W. Grainger, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
